P44. Activin A is novel circulating biomarker in lung cancer

BACKGROUND: Therapeutic decision making for the treatment of lung cancer is often a complex and challenging task. Biomarkers are urgently needed that can facilitate the early detection of these malignant diseases and can predict which therapeutic modality can significantly contribute to tumor contro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Rozsas, Anita, Hoda, Mir Alireza, Klikovits, Thomas, Schlech, Karin, Laszlo, Viktoria, Grusch, Michael, Berger, Walter, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2014
Matèries:
CELCC 2014 Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367750/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB056
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars